EcoDrugPlus

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSTRUG00000016527
Gene Symbol: FGFR1
3 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSTRUG00000018627
Gene Symbol: FGFR1
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSTRUG00000017610
Gene Symbol: FGFR2
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSTRUG00000003670
Gene Symbol: FGFR3
1 Cross references
193 Possible Orthologues:

Fms Related Tyrosine Kinase 1

Ensembl ID : ENSTRUG00000006184
Gene Symbol: FLT1
3 Cross references
198 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSTRUG00000005654
Gene Symbol: FLT4
3 Cross references
193 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSTRUG00000008489
Gene Symbol: FOLH1B
3 Cross references
339 Possible Orthologues:

Folate Receptor

Ensembl ID : ENSTRUG00000009430
Gene Symbol: FOLR
2 Cross references
436 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSTRUG00000022889
Gene Symbol: LOC105416602
3 Cross references
337 Possible Orthologues:

Free Fatty Acid Receptor 2-Like

Ensembl ID : ENSTRUG00000002806
Gene Symbol: LOC115250497
2 Cross references
337 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSTRUG00000006360
Gene Symbol: FRK
4 Cross references
202 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSTRUG00000011994
Gene Symbol: GLA
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).